Home > Balance Sheet > GLAND PHARMA

GLAND PHARMA
Deferred Tax Assets / Liabilities

    Back to Balance Sheet
GLAND PHARMA is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Top Undervalued Small Cap Stocks
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year Deferred Tax Assets / Liabilities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Deferred Tax Assets / Liabilities ₹170 Cr₹84 Cr₹88 Cr₹74 Cr₹74 Cr

What is the latest Deferred Tax Assets / Liabilities ratio of GLAND PHARMA ?

The latest Deferred Tax Assets / Liabilities ratio of GLAND PHARMA is ₹170 Cr based on Mar2024 Consolidated results.
Year Deferred Tax Assets / Liabilities
Mar2024₹170 Cr
Mar2023₹84 Cr
Mar2022₹88 Cr
Mar2021₹74 Cr
Mar2020₹74 Cr

How is Deferred Tax Assets / Liabilities of GLAND PHARMA Trending?

Years Deferred Tax Assets / Liabilities % Change
Mar2024 ₹170 Cr
101.52
Mar2023 ₹84 Cr
-4.05
Mar2022 ₹88 Cr
18.79
Mar2021 ₹74 Cr
-0.23
Mar2020 ₹74 Cr -

Compare Deferred Tax Assets / Liabilities of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹30,637.1 Cr -0.9% 11.5% -9.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹401,289.0 Cr -0.4% -0.9% 4.8% Stock Analytics
DIVIS LABORATORIES ₹181,397.0 Cr -0.7% 1.6% 50.2% Stock Analytics
CIPLA ₹119,955.0 Cr -1.7% -1.1% -2.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹112,132.0 Cr -1.1% 1.6% 13.7% Stock Analytics
DR REDDYS LABORATORIES ₹104,657.0 Cr -4.3% -8% -4.4% Stock Analytics


GLAND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

-0.9%

11.5%

-9.1%

SENSEX

-1.1%

-0%

3.2%


You may also like the below Video Courses